Question 1

Has Jane Lynch received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $515,827 in general payments to Jane Lynch across 782 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Jane Lynch did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Jane Lynch come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Novo Nordisk AS	649	$292,836
Boehringer Ingelheim	6	$120,253
Boehringer Ingelheim Pharma GmbH & Co.kg	18	$77,562
Dexcom, Inc.	4	$10,540
Boehringer Ingelheim France S.a.s.	18	$6,799
Novo Nordisk	33	$4,906
Daiichi Sankyo Inc.	1	$1,557
BETA Bionics, Inc.	5	$224
Sanofi-aventis U.S. LLC	3	$147
Tolmar, Inc.	6	$129
Kyowa Kirin, Inc.	6	$122
Abbott	6	$120
Ascendis Pharma Endocrinology Inc	5	$114
Eton Pharmaceuticals, Inc.	1	$104
Azurity Pharmaceuticals, Inc.	3	$64
Insulet Corporation	3	$59
Soleno Therapeutics, Inc.	2	$56
Pfizer	3	$54
Lilly USA, LLC	3	$53
Arbor Pharmaceuticals, Inc.	2	$36
Medtronic	2	$31
Neurocrine Biosciences, Inc.	1	$22
AbbVie	1	$20
Xeris Pharmaceuticals, Inc.	1	$18

Jane Lynch

Payments from drug & device makers

Who reported the general payments

How this compares

Other pediatric endocrinology in San Antonio